Abstract
Background
p63 and p16 have been described as stem-cell markers of squamous epithelium. In an attempt to obtain new insights into the pathogenesis of pterygium, this study aims to evaluate the relationship between p63 and p16 expression in primary and recurrent pterygia.
Methods
Samples of primary (n=56) and recurrent (n=14) pterygia and normal bulbar conjunctival tissue (n=11) were submitted to immunohistochemical study to evaluate the expression of p63 and p16 in these tissues.
Results
Most of the cells stained for p63 were located in the basal layer of the normal conjunctiva, in the lower two-thirds of the epithelium of primary pterygia, and throughout all epithelial layers of recurrent pterygia. In normal conjunctivae, p16 expression was rarely expressed. Primary and recurrent pterygium groups exhibited increased p16 expression, with cytoplasmic staining in the primary group, and cytoplasmic or nuclear staining in the recurrent group.
Conclusion
The overexpression of p63 and p16 observed in the present study reinforces likelihood of involvement of these genes in the pathogenesis of pterygium, perhaps related to the intense cellular turnover with substitution of superficial epithelial cells by less differentiated forms. This loss of normal cellular differentiation of the epithelial layers could explain the high rates of recurrence overall in the recurrent pterygia.
Similar content being viewed by others
References
Au NH, Gown AM, Cheang M, Huntsman D, Yorida E, Elliott WM, Flint J, English J, Gilks CB, Grimes HL (2004) p63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol 12:240–247
Austin P, Jakobiec FA, Iwamoto T (1983) Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 90:96–109
Auw-Haedrich C, Sundmacher R, Freudenberg N, Spelsberg H, Feltgen N, Maier P, Reinhard T (2005) Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol 15:1–8
Clear AS, Chirambo MC, Hutt MSR (1979) Solar keratosis, pterygium, and squamous cell carcionoma of the conjunctiva in Malawi. Br J Ophthalmol 63:102–109
Coroneo MT, Di Girolamo N, Wakefield D (1999) The pathogenesis of pterygia. Curr Opin Opthalmol 10:282–288
Coroneo MT (1993) Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol 77:734–739
Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494–501
Di Girolamo N, Coroneo MT, Wakefield D (2003) UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci 11:4705–4714
Di Iorio E, Barbaro V, Ruzza A, Ponzin D, Pellegrini G, De Luca M (2005) Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc Natl Acad Sci USA 102:9523–9528
Dushku N, Reid TW (1994) Immunohistochemical evidence that human pterygia originate from the invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 13:473–481
Gologan O, Barnes EL, Hunt JL (2005) Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol 6:792–796
Hodges A, Smoller BR (2002) Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 11:1121–1125
Hussein MR (2005) Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 3:191–205
Irwin MS, Kaelin WG (2001) P53 family update: p73 and p63 develop their own identities. Cell Growth Differ 12:337–349
Kaufmann O, Fietze E, Mengs J, Dietel M (2001) Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823–830
Maisse C, Guerrieri P, Melino G (2003) P73 and p63 protein stability: the way to regulate function? Biochem Pharmacol 66:1555–1561
Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL (2003) Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 21:7113–7121
Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM,McGuinness E, Sheils O, O’Leary JJ (2005) p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 5:525–534
Nilsson K, Svensson S, Landberg G (2004) Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod Pathol 12:1464–1474
Pavey S, Conroy S, Russell T, Gabrielli B (1999) Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Res 17:4185–4189
Reis-Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443:122–132
Reis-Filho JS, Torio B, Albergaria A, Schmitt FC (2002) P63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 9:517–523
Sakoonwatanyoo P, Tan DT, Smith DR (2004) Expression of p63 in pterygium and normal conjunctiva. Cornea 1:67–70
Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D (1998) A new human p53 homologue. Nat Med 4:747–748
Wang IJ, Hu FR, Chen PJ, Lin CT (2000) Mechanism of abnormal elastin gene expression in the pinguecular part of pterygia. Am J Pathol 4:1269–1276
Westfall MD, Pietenpol JA (2004) P63: molecular complexity in development and cancer. Carcinogenesis 25:857–864
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant negative activities. Mol Cell 2:305–316
Acknowledgement
The authors would like to thanks to Auristella de Mello Martins for the technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Research supported by FAEPA and CAPES.
Rights and permissions
About this article
Cite this article
Ramalho, F.S., Maestri, C., Ramalho, L.N.Z. et al. Expression of p63 and p16 in primary and recurrent pterygia. Graefe's Arch Clin Exp Ophthalmo 244, 1310–1314 (2006). https://doi.org/10.1007/s00417-006-0287-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-006-0287-5